- Kowa owns manufacturing plants in Nagoya, Fuji, Hamamatsu, Mohka and Chofu for the production of its OTC, quasi-drugs, prescription drugs and medical devices.
- Quality assurance
- We maintain an effective production management system in compliance with the Good Quality Practice (GQP) for pharmaceutical products to assure the high quality and reliability of our products.
Taking advantage of our experiences in pharmaceuticals, we are making our efforts, on dietary supplements, to construct a production and quality management on the manufacturing plants which meet Good Manufacturing Practice (GMP) for dietary supplements. This assures the high quality and reliability of our products.
- Safety management
- We have built and continue to maintain an effective safety management system in compliance with the Good Vigilance Practice (GVP), which allows us to collect information on adverse drug reactions from around the world. We then carefully evaluate and review this information to ensure that our products are used correctly, and immediately take safety measures if required.